Soft-tissue sarcoma: Mayo Clinic experience.
Soft-tissue tumors encompass a wide variety of lesions and continue to pose a difficult treatment problem. The outlook, however, is improving, and there have been recent advances in pretreatment assessment, clinicopathologic correlation, and adjuvant treatment programs. We retrospectively reviewed our experience in a large series of soft-tissue tumors treated at the Mayo Clinic as well as recent experience using chemotherapy and radiation treatment.
Sim
F H
FH
Department of Orthopedics, Mayo Clinic, Rochester, Minnesota 55905.
Pritchard
D J
DJ
Reiman
H M
HM
Edmonson
J H
JH
Schray
M F
MF
D000328:Adult; D003131:Combined Modality Therapy; D005260:Female; D018219:Histiocytoma, Benign Fibrous / Q000628:therapy; D006801:Humans; D008297:Male; D011379:Prognosis; D012189:Retrospective Studies; D012509:Sarcoma / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D013584:Sarcoma, Synovial / Q000628:therapy; D012983:Soft Tissue Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*